ArticlePathogens (Basel, Switzerland)2023
Comparison of Three Serologic Tests for the Detection of Anti-
Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 16 citations in OpenAlex.
- Article
- Comparison of in-house immunofluorescence assay (IFA) and commercial enzyme-linked immunosorbent assay (ELISA) for Coxiella burnetii infection in cattle.Veterinary research communications · 2025Article
- Coxiella burnetii and HIV infection in people experiencing homelessness.Scientific reports · 2025Article
- One health behind bars: Seroincidence ofOne health (Amsterdam, Netherlands) · 2025Article
- Prevalence of Acute Q Fever Among High-Risk Patients With Fever and Pneumonia Symptoms in Western Iran.Journal of tropical medicine · 2025Article
- Article
- Article
- One Health approach to Coxiella burnetii in Brazilian indigenous communities.Scientific reports · 2024Article
- Serosurvey ofTropical medicine and infectious disease · 2024Article
- Serosurvey ofMicroorganisms · 2024Article
- Article
- Case report: a missed case of chronic Q fever infective endocarditis demonstrating the ongoing diagnostic challenges.Access microbiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Funding
Abstract
The performance of a commercial immunofluorescence assay (IFA commercial), an
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.